Theralase Technologies Inc.
TLTFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $269 | $44 | $1,509 | $3,692 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $547 | $388 | $196 | $86 |
| Inventory | $545 | $658 | $486 | $566 |
| Other Curr. Assets | $222 | $409 | $311 | $654 |
| Total Curr. Assets | $1,584 | $1,499 | $2,501 | $4,998 |
| Property Plant & Equip (Net) | $606 | $858 | $1,107 | $866 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,057 | $920 | $553 | $81 |
| Total NC Assets | $1,663 | $1,778 | $1,660 | $947 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,247 | $3,277 | $4,161 | $5,945 |
| Liabilities | – | – | – | – |
| Payables | $362 | $682 | $328 | $496 |
| Short-Term Debt | $100 | $93 | $87 | $36 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $523 | $302 | $267 | $343 |
| Total Curr. Liab. | $986 | $1,077 | $681 | $875 |
| LT Debt | $194 | $294 | $387 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $194 | $294 | $387 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $294 | $387 | $474 | $36 |
| Total Liabilities | $1,180 | $1,371 | $1,068 | $875 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $48,924 | $46,436 | $44,527 | $42,120 |
| Retained Earnings | -$67,496 | -$63,240 | -$58,452 | -$53,092 |
| AOCI | $3,058 | $6,219 | $5,643 | $5,098 |
| Other Equity | $17,582 | $12,491 | $11,374 | $10,944 |
| Total Equity | $2,067 | $1,905 | $3,093 | $5,070 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,247 | $3,277 | $4,161 | $5,945 |
| Net Debt | $25 | $343 | -$1,035 | -$3,656 |